Home
overview

For the latest COVID-19 Travel restrictions and recommendations please click here

SAE Media Group and Medical Design Briefs Present
Biosensors for Medical Wearables
October 24-25, 2022 |
-------------------------------------------------------------------------------------------

SAE Media Group and Medical Design Briefs are proud to present the Biosensors for Medical Wearables Conference, taking place on the 24th - 25th October 2022.

The global wearable biosensors market is a rapidly expanding industry with increasingly growing potential for applications in healthcare and technological advances. With potential in remote patient monitoring, diagnosis and detection of disease, biosensors and wearable devices are gaining substantial interest due to their opportunities to offer continuous and reliable physiological information allowing for better support of patient needs.


 

As part of SAE Media Group’s leading series of medical device conferences, this year’s event will be exploring the key drivers and innovations of the wearable medical biosensors landscape with insights into the latest technologies uncovering the therapeutic scope of medical biosensors and the potential of wearable sensors for decentralized diagnostic testing. Furthermore, this year’s conference will look at how industry is overcoming unmet needs including battery technologies and flexibility for wearable sensors. With growing digital application, the 2022 agenda will also assess the potential of Artificial Intelligence coupled with sensors and understand how industry is managing digital outcomes.
 

  • Explore the latest in biosensor technologies for wearable medical devices for therapeutics applications
  • Uncover the potential of wearable sensors for decentralized diagnostic testing
  • Delve into the evolving research and technologies to overcome unmet needs of the field including flexible sensors and regulatory updates
  • Assess the growing opportunities and sensor technologies being developed in industry for digital medicine and therapeutics through interactive panel discussions
  • Engage in platforms and opportunities for sensors coupled with AI and understand how industry are managing digital outcomes

Executives, Directors, VPs, Heads, Principals, Managers of:

Digital health and connectivity
Smart device developers
Device manufacturers
Biosensors
Wearable devices
Connected Devices
Microneedle Patches
Human Factors
Packaging
Regulatory Affairs
Medical Device Data
 

AJOU UNIVERSITY; Amgen; Aparito; AstraZeneca; BioIntelliSense, Inc.; BloomerTech; Boston University School of Medicine; Cambridge Design Partnership; Celanese; ChroniSense Medical; Columbia University; Digital Medicine Society; EPIWatch; Focus Academy; GSK; Huma; Huma Therapeutics Limited; J & J Healthcare Systems; J & J Pharmaceutical; Janssen Pharmaceuticals; Janssen R&D; Jazz Pharmaceuticals; Johnson & Johnson; Medical Device Consultancy; MedRhythms; Merck; Merck Group; Novartis; Novartis Pharmaceuticals Corporation; NSF Center for Advanced Self-Powered Systems of Integrated Sensors and Technologies ; Penn State University; Pfizer; Pfizer Inc; Qura Inc; S2N Health; Starfish Medical; SureMed Technologies, Inc.; Swansea University; Takeda Pharmaceutical Company Limited; UserWise, Inc.;
 

Conference programme

8:00 Registration & Coffee

9:00 Chairman's Opening Remarks

James Mault, MD

James Mault, MD, Founder and CEO, BioIntelliSense, Inc.
View Bio

9:10 Medical Grade Wearables and Continuous Remote Monitoring from In-Hospital to Home

James Mault, MD

James Mault, MD, Founder and CEO, BioIntelliSense, Inc.
View Bio

  • A new generation of medical grade wearable sensors can enable continuous multi-parameter patient monitoring both in-hospital and at-home.
  • With the effortless simplicity of passive continuous monitoring, the asynchronous data streams generated by these wearable devices, combined with scalable exception management algorithms, enable more proactive, efficient and scalable models of care.
  • These new remote care technology solutions can reduce length of stay, detect negative trends early in their course, and deliver better care to more patients at a fraction of the cost.
  • 9:50 Designing wearables for real-time clinical thinking algorithms

    Eric Richardson

    Eric Richardson, Vice President, MedRhythms
    View Bio

  • In digital therapeutic devices, there are a class of products whose clinical responses are delivered synchronously to the patient based on real-time inputs from biosensors. These devices differ from wearables that track biomarkers and activities on daily hourly or daily basis.
  • Real-time wearables don’t have the luxury of post-processing entire data sets. Hardware and algorithm design must accommodate the constraints of data processing with low-latency and high reliability requirements,
  • using machine learning and other techniques early in the data acquisition pipeline.
  • Wireless biosensors are preferred, so edge processing algorithms on the biosensor hardware reduces data transmission and conserves battery life.
  • This presentation will discuss design strategies that balance the competing requirements of real-time medical wearables.
  • 10:30 Morning Coffee

    11:00 Cala Trio: Using Biosensors to personalize treatment of tremors

  • Incorporating sensors to benefi t patient experience
  • Overview of CALA Trio therapy
  • How each of CALA trio’s sensors improve patient therapy
  • Greg Schulte

    Greg Schulte, VP of Hardware, CALA
    View Bio

    11:40 Monitoring a post-surgical episode of care using wearable technologies

    Richard Bolander

    Richard Bolander, Senior Wearable Design Engineer, TracPatch Health
    View Bio

  • Developing a multi-sensor array to characterize range of motion across a joint
  • Incorporating patient – centric features to increase the probability of success of an intervention
  • Creating a holistic solution to bridge the gap between patients and providers
  • Analysing episode of care data to solve challenges within in the musculoskeletal space
  • 12:20 Enabling remote cardiac monitoring to detect major heart disease

    Tero-Pekka Alastalo

    Tero-Pekka Alastalo, Chief Medical Officer and General Manager, US Operations, CardioSignal Inc
    View Bio

  • Introducing a new approach to remote heart health monitoring with motion sensor technology: Gyrocardiography, a non-invasive technique for assessing heart motion
  • Technology that can run on smartphones, offering unmatched accessibility in virtual care models
  • A high-quality signal: Accurate performance with a wide range of smartphone models and different body characteristics. Presenting results from our multi-center clinical studies, and published clinical and technical validations
  • Technology that enables detection of major heart disease, such as heart failure, coronary artery disease and aortic stenosis
  • 13:00 Networking Lunch

    14:00 Wearable device integration of neurophysiological diagnostic and therapeutic capabilities

    John Ralston

    John Ralston, CEO and Founder, Neursantys, Inc.
    View Bio

  • Assessing the utility of non-invasive wearable sensors to classify and quantify impairments to multiple neurophysiological systems
  • Assessing the utility of non-invasive neurostimulation techniques to counteract neurophysiological disruptions caused by aging, injuries, or disease
  • Addressing challenges in the design, prototyping, and manufacturing of devices that integrate the above diagnostic and therapeutic capabilities into an unobtrusive wearable form factor
  • Applications to a growing range of neurological conditions, including concussions, vestibular disorders, Parkinson’s disease, stroke, multiple sclerosis, peripheral neuropathies, and invasive neurosurgeries
  • 14:40 Assessing accuracy, reliability and usability of in-ear vital signs monitoring

  • An introduction to the current landscape of vital signs monitoring
  • Verifying biosensor features and applicability for continuous monitoring of vital signs
  • Human factors considerations for in-ear wearable device design
  • Components of remote patient monitoring systems for detection, analysis, and transmission of raw data
  • Johannes Kreuzer

    Johannes Kreuzer, CEO, Cosinuss
    View Bio

    15:20 No two devices are created equal

  • The past, present and future of sensor-based digital health technology (DHT) and novel digital endpoints (NDEs) for use in clinical investigations and beyond.
  • How technology and pharma can work together to continue the advancement of DHTs and novel clinical endpoints in clinical trials
  • Case Study: Wearable device comparisons and sensor performance evaluation
  • Carrie Northcott

    Carrie Northcott, Director and Project Lead, Pfizer Inc
    View Bio

    Christine Guo

    Christine Guo, Chief Scientific Officer, ActiGraph
    View Bio

    16:00 Afternoon Tea

    16:30 Integrating sensor generated data into data platforms to power clinical research and patient care

    Jennifer Goldsack

    Jennifer Goldsack, CEO, Digital Medicine Society
    View Bio

  • A cross-industry collaboration to articulate value, define needs, and advance a framework for best practices
  • Challenges in data handling to practically introducing sensors at scale in clinical research and patient care environments
  • What does the industry need with regard to regulations, standards and guidance to accelerate the opportunities of sensor data in medicine?
  • Takeaways from the study: next steps for industry to allow clinicians, patients, and researchers to use sensor generated data to make better decisions, faster
  • 17:10 What does the future hold for Medical Wearable Biosensors

    Chief of Medical Design Briefs, Sherrie Trigg, will be engaging with recognised thought leaders of the industry: American Telemedicine Association (ATA) board member; James Mault, MD, and CEO of the Digital Medicine Society (DiMe); Jennifer Goldsack.


    Our esteemed panellists will discuss the growing potentials of this exciting industry, engaging in highlights of their experiences of the evolving landscape of wearable sensors, the latest trends to watch out for, and insights into the future of this rapidly accelerating field of medicine.

    Sherrie Trigg

    Sherrie Trigg, Director of Medical Content and Editor-in-Chief, Medical Design Briefs

    James Mault, MD

    James Mault, MD, Founder and CEO, BioIntelliSense, Inc.
    View Bio

    Jennifer Goldsack

    Jennifer Goldsack, CEO, Digital Medicine Society
    View Bio

    17:50 Chair’s Closing Remarks and Close of Day One

    8:00 Registration & Coffee

    9:00 Chairman's Opening Remarks

    Andreas Caduff

    Andreas Caduff, Strategic Advisory Board, Digital Medicine Society (DiMe)
    View Bio

    9:10 Assessing the evolving landscape of wearable devices for monitoring and remote diagnostics

    Andreas Caduff

    Andreas Caduff, Strategic Advisory Board, Digital Medicine Society (DiMe)
    View Bio

  • Growing technologies in wearable monitoring in health and medicine
  • Analyzing the use of consumer technology for medical applications: the good and bad
  • Uncovering the biosensor technologies to look out for in the near future
  • The sky’s the limit – how should industry be focusing their R&D for optimal opportunities from sensor technologies?
  • 9:50 What is Electromagnetic Compatibility and Why do Regulators Want Your Biosensors to Comply?

    Samir Shah

    Samir Shah, Director, AstraZeneca
    View Bio

  • Disasters caused by electromagnetic disturbances
  • What is 60601-1-2 and what do all the terms mean?
  • Why regulators still ask for testing on electronics while relaxing requirements on software
  • 10:30 Morning Coffee

    11:00 Panel Discussion: Decentralized Trial Design for Today and the Future

    James Mault, MD

    James Mault, MD, Founder and CEO, BioIntelliSense, Inc.
    View Bio

  • The growth of connected devices, medical-grade data and remote technologies is setting the stage for a more
  • decentralized future for clinical trials.
  • Learn about clinical trial design that addresses the challenges of access, diversity and equity.
  • What are the emerging technology platforms that are helping to facilitate decentralized trials and what is still needed to support decentralized trials for the future?
  • 11:40 Transforming the delivery of health care through advanced sensor measurement

    Xina Quan

    Xina Quan, Co-founder and CEO, PyrAmes, Inc
    View Bio

  • Challenges in accurate blood pressure measurement for newborns to seniors
  • The technology behind PyrAmes’ flexible sensors for non-invasive continuous blood pressure monitoring
  • Supportive evidence for the FDA-designated breakthrough device
  • Next steps and future applications for the flexible sensor
  • 12:20 Overcoming challenges in long-term adhesives for wearable sensors

  • Assessing the growing landscape of smart clothing for medical applications
  • Challenges in long-term medical wearables and insights into the design and development of flexible textile sensors to overcome hurdles in adhesives
  • Case Studies of cardiac, pulmonary and respiratory medical application of smart textile sensors
  • Uncovering the future potential and opportunities to further long-term medical sensor technologies
  • Pierre-Alexandre Fournier

    Pierre-Alexandre Fournier, Co-founder/CEO, Hexoskin
    View Bio

    13:00 Networking Lunch

    14:00 Pairing Remote EEG Monitoring with Large-Scale Computing to Go Beyond the Analysis Capabilities of Human Experts

  • Wearable biosensors will provide scalable continuous brain health metrics to accelerate precision medicine for patients with severe neurological disease.
  • The rise of machine learning and improvement in wearable sensor technologies has created a unique moment in time where EEG will become scalable in a way that was never possible with traditional hardware and expert-dependent interpretation.
  • Novel machine learning algorithms and large clinical datasets are poised to transform how brain disorders are treated. Using clinical-grade data from remote EEG monitoring, machine learning accelerates the discovery of neurobiomarkers and the development of new treatments for patients with neurological, psychiatric or sleep
  • disorders.
  • Neurobiomarkers are helping to progress new discoveries from development to targeted deployment into clinical trials and novel therapeutic areas.
  • Jacob Donoghue

    Jacob Donoghue, CEO and Co-Founder, Beacon Biosignals
    View Bio

    14:40 What’s new in wearable biosensors and AI/ML-based remote patient management

    Jaydev Thakkar

    Jaydev Thakkar, COO, Biofourmis
    View Bio

  • How artificial intelligence (AI)/machine learning (ML) coupled with biosensors can improve drug safety and efficacy
  • How Chugai and Biofourmis are leveraging wearables and AI/ML to identify objective measures of pain in clinical studies
  • Ten years after the first patient was treated with CAR-T therapy: Sensors and predictive analytics monitor patients post-treatment to prevent life-threatening issues
  • Future clinical and therapeutic potential of AI/ML coupled with biosensors
  • 15:20 Afternoon Tea

    15:50 Panel Discussion: Clinical Value and Utility of Advancements in Remote Core Technologies

    James Mault, MD

    James Mault, MD, Founder and CEO, BioIntelliSense, Inc.
    View Bio

  • Exploring the fast-growing capabilities of wearables in the clinic as a result of developments in technologies
  • How are monitoring technologies being used to evolve a standard of care within the walls of hospitals and health system facilities?
  • How can data driven continuous care models start to automate care?
  • The ongoing pathway of monitoring patients with complex care needs
  • 16:30 Tales from the Trenches

    Kate Gunning

    Kate Gunning, Managing Partner, Focus Academy
    View Bio

  • Considerations in commercializing health technology
  • Incorporating meaningful data for adoption
  • Data integration and dataflows for healthcare decision making
  • Strategic planning and evidence building discussion
  • 17:10 Chair’s Closing Remarks and Close of Day Two

    +

    FEATURED SPEAKERS

    Carrie Northcott

    Carrie Northcott

    Director and Project Lead, Pfizer Inc
    Christine Guo

    Christine Guo

    Chief Scientific Officer, ActiGraph
    Eric Richardson

    Eric Richardson

    Vice President, MedRhythms
    Greg Schulte

    Greg Schulte

    VP of Hardware, CALA
    Jacob Donoghue

    Jacob Donoghue

    CEO and Co-Founder, Beacon Biosignals
    James Mault, MD

    James Mault, MD

    Founder and CEO, BioIntelliSense, Inc.
    Jaydev Thakkar

    Jaydev Thakkar

    COO, Biofourmis
    Jennifer Goldsack

    Jennifer Goldsack

    CEO, Digital Medicine Society
    Johannes Kreuzer

    Johannes Kreuzer

    CEO, Cosinuss
    John Ralston

    John Ralston

    CEO and Founder, Neursantys, Inc.
    Kate Gunning

    Kate Gunning

    Managing Partner, Focus Academy
    Pierre-Alexandre Fournier

    Pierre-Alexandre Fournier

    Co-founder/CEO, Hexoskin
    Richard Bolander

    Richard Bolander

    Senior Wearable Design Engineer, TracPatch Health
    Samir Shah

    Samir Shah

    Director, AstraZeneca
    Sherrie Trigg

    Sherrie Trigg

    Director of Medical Content and Editor-in-Chief, Medical Design Briefs
    Tero-Pekka Alastalo

    Tero-Pekka Alastalo

    Chief Medical Officer and General Manager, US Operations, CardioSignal Inc
    Xina Quan

    Xina Quan

    Co-founder and CEO, PyrAmes, Inc

    Andreas Caduff

    Strategic Advisory Board, Digital Medicine Society (DiMe)
    Andreas Caduff

    Andreas Caduff has been a driving force in the development of non-invasive and contextualized physiological monitoring. He was serving as CTO of Solianis where he orchestrated the development of non-invasive glucose monitoring. He then founded Biovotion and served for 7 years as CEO, offering a state-of-the-art user-centric, analytics driven ecosystem, powered by medical wearable technology. Biovotion received several international awards and high calibre endorsements for its innovations, including an award from the XPrize Foundation. Biovotion was acquired by Biofourmis in 2019. Today he is working at the interface of secured medical technology, physiological monitoring and data science, towards a more holistic view of health.

    Carrie Northcott

    Director and Project Lead, Pfizer Inc
    Carrie Northcott

    Christine Guo leads the clinical and data science team at ActiGraph, responsible for the scientific strategy and services supporting ActiGraph's leadership in digital health technology. Christine brings 15+ years’ experience in clinical research and a vision for leveraging technology in clinical trials and practice. Prior to ActiGraph, Christine was Head of Scientific Innovation at Biogen Healthcare Solutions, leading the clinical development and validation of Biogen's digital health products (Software as Medical device) in multiple sclerosis, neuromuscular and neurodegenerative diseases. Christine brings unique scientific insights by bridging across clinical and technical disciplines and is passionate about leveraging data and technology to improve people's health. Christine holds a B.A. in biological sciences from Peking University and Ph.D. in neuroscience from Stanford university.

    Christine Guo

    Chief Scientific Officer, ActiGraph
    Christine Guo

    Christine Guo leads the clinical and data science team at ActiGraph, responsible for the scientific strategy and services supporting ActiGraph's leadership in digital health technology. Christine brings 15+ years’ experience in clinical research and a vision for leveraging technology in clinical trials and practice. Prior to ActiGraph, Christine was Head of Scientific Innovation at Biogen Healthcare Solutions, leading the clinical development and validation of Biogen's digital health products (Software as Medical device) in multiple sclerosis, neuromuscular and neurodegenerative diseases. Christine brings unique scientific insights by bridging across clinical and technical disciplines and is passionate about leveraging data and technology to improve people's health. Christine holds a B.A. in biological sciences from Peking University and Ph.D. in neuroscience from Stanford university.

    Eric Richardson

    Vice President, MedRhythms
    Eric Richardson

    Eric Richardson has worked in the digital media and audio technology industries for over twenty-five years, during which time he honed his talent for business development, strategic marketing, and product management for several international public companies. Eric’s executive responsibilities included high value account development, R&D team leadership, and strategic partner relationships.

    Eric is currently a member of the software engineering team at MedRhythms, and contributes his extensive knowledge of music cognition and mobile application engineering. He is passionate about music and is thrilled that it can improve people’s lives in a meaningful way.

    Previously, Eric was president of Fwave, Inc., a software product development company that created EnTrainer, a mobile app for musical running, as well as a cybersecurity simulation platform for global financial institutions. Eric graduated with a B.A. from Dartmouth College, received a diploma in Audio Engineering and Music Production from Berklee College of Music and is a Masters candidate in Digital Musics at Dartmouth College.

    Eric gets wet as a competitive sailor and wishes ski seasons lasted a little bit longer. He can sometimes be seen playing bass in his jazz quartet.

    Greg Schulte

    VP of Hardware, CALA
    Greg Schulte

    Greg has 20 years of experience in product strategy, design, and engineering for companies and clients of all sizes focused in medical, utility, and consumer electronics. A mechanical engineer by training, Greg cofounded Guide Medical Ventures in 2011, managing strategic vision and technology for a portfolio of 6 start-ups in the medical device space. Prior to joining Cala Health, Greg led engineering at Mindtribe, a boutique hardware development consultancy acquired by Accenture. Greg started his career at Medtronic as a mechanical design engineer in neurological leads and honed his engineering leadership at Intelect Medical (acquired by Boston Scientific), Enpath Medical and EnteroMedics.

    Jacob Donoghue

    CEO and Co-Founder, Beacon Biosignals
    Jacob Donoghue

    Jake translates scientific innovation into clinical interventions. He recently completed his MD from Harvard Medical School and PhD in neuroscience from MIT, leading research into the effects of neuroactive compounds on brain network activity. His published works span epilepsy, cognition and machine learning methods for quantifying pharmacological effects on neural activity.

    James Mault, MD

    Founder and CEO, BioIntelliSense, Inc.
    James Mault, MD

    James Mault, MD, FACS, is the Founder and Chief Executive Officer of BioIntelliSense, a Data-as-a-Service (DaaS) platform company, delivering breakthrough medical-grade biosensor technology with unique clinical intelligence for scalable remote patient monitoring.

    Prior to BioIntelliSense, Dr. Mault served as Senior Vice President and Chief Medical Officer of Qualcomm Life for over five years, where his leadership responsibilities included Strategic Planning and Business Development, Mergers and Acquisitions, New Product Innovation, Clinical Program and Regulatory Oversight, Health Policy and Government Affairs, Global Spokesperson and Public Relations. Dr. Mault came to Qualcomm Life through its 2013 acquisition of HealthyCircles, a Care Coordination and Remote Patient Monitoring Platform Company founded and led by Dr. Mault in 2009. Prior to starting HealthyCircles, he was the Medical Director of the Health Solutions Group at Microsoft.

    Dr. Mault has more than 35 years of experience in senior executive positions in the Health IT and Medical Device industry as well as clinical medicine. He has founded five Health IT and medical device companies, raising over $150 million in working capital and leading these companies to develop novel devices and software technologies, FDA approvals, strategic partnerships with numerous Fortune 500 companies, culminating in M&A or IPO exit transactions. He is the named inventor of over 80 issued and pending patents for a variety of novel health IT and medical device innovations. He has been board-certified in both General Surgery and Cardiothoracic Surgery, having specialized in heart and lung transplantation, thoracic oncology and critical care. He has conducted academic medical research under grant awards from the National Institutes of Health, American Cancer Society, and others. He is the author of more than 60 scientific articles, chapters and books in the published medical literature.

    Dr. Mault received his B.S. in Biology and Medical Degree from the University of Michigan and conducted his General Surgery and Cardiothoracic Surgery residency training at Duke University Medical Center. Dr. Mault provides global thought-leadership on the future of technology and healthcare delivery, serving on numerous Boards and leadership positions including the Board of Directors of Bose Corporation, Executve Board of the Consumer Technology Association’s (CTA), Chairman of the American Telemedicine Association Clinical Trials Board and the Board of Trustees for the Astronaut Scholarship Foundation.
     

    Jaydev Thakkar

    COO, Biofourmis
    Jaydev Thakkar

    Jaydev Thakkar, Chief Operating Officer of Biofourmis, has over 25 years’ experience in leadership roles in the world’s leading pharma and biotech organizations, from Fortune 100 powerhouses to groundbreaking startups, where he boasts an accomplished record of sparking technology innovations; forming strategic alliances; and leading global IT, software engineering, and architecture teams. At Biofourmis, Mr Thakkar leads the strategy and execution of Biofourmis’ digital therapeutics pipeline and running its clinical research operations, manufacturing operations and supply chain aspects. In his most recent role prior to Biofourmis, Mr Thakkar served as director of Digital Health and Innovation at Amgen for 14 years, where he led its “beyond the therapy” digital innovation strategy to maximize product value and clinical outcomes across the patient journey
     

    Jennifer Goldsack

    CEO, Digital Medicine Society
    Jennifer Goldsack

    Jennifer C. Goldsack co-founded and serves as the CEO of the Digital Medicine Society (DiMe), a 501(c)(3) non-profit organization dedicated to advancing digital medicine to optimize human health. Jennifer’s research focuses on applied approaches to the safe, effective, and equitable use of digital technologies to improve health, healthcare, and health research. She is a member of the Roundtable on Genomics and Precision Health at the National Academies of Science, Engineering and Medicine and serves on the World Economic Forum Global Leadership Council on mental health.

    Previously, Jennifer spent several years at the Clinical Trials Transformation Initiative (CTTI), a public-private partnership co-founded by Duke University and the FDA. There, she led development and implementation of several projects within CTTI’s Digital Program and was the operational co-lead on the first randomized clinical trial using FDA’s Sentinel System.

    Jennifer spent five years working in research at the Hospital of the University of Pennsylvania, first in Outcomes Research in the Department of Surgery and later in the Department of Medicine. More recently, she helped launch the Value Institute, a pragmatic research and innovation center embedded in a large academic medical center in Delaware.

    Jennifer earned her master’s degree in chemistry from the University of Oxford, England, her masters in the history and sociology of medicine from the University of Pennsylvania, and her MBA from the George Washington University. Additionally, she is a certified Lean Six Sigma Green Belt and a Certified Professional in Healthcare Quality. Jennifer is a retired athlete, formerly a Pan American Games Champion, Olympian, and World Championship silver medalist.
     

    Johannes Kreuzer

    CEO, Cosinuss
    Johannes Kreuzer

    Dr. Johannes Kreuzer studied electronic engineering at the Technical University of Munich from 2000-2005. Topic of his PhD was vital signs monitoring in daily life. During university time and later, he worked for companies like Epcos, EADS, Airbus, Daimler and Pilatus. Together with his wife Greta he founded the company cosinuss° end of 2011. cosinuss° is a technology company based in Munich and specialized on in-ear vital signs monitoring for sports, medicine and workers safety.

    John Ralston

    CEO and Founder, Neursantys, Inc.
    John Ralston

    Dr. Ralston is a pioneer in the integration of clinical grade wearable devices and advanced data analytics to improve patient access to unobtrusive continuous and remote healthcare management. At Neursantys he is focused on improving the diagnosis and treatment of complex neurophysiological conditions caused by aging, injuries, and disease, in collaboration with healthcare delivery and research teams working to improve patient care and reduce healthcare delivery costs. John earned B.Sc. degrees in Physics and Electrical Engineering from M.I.T., a PhD in Electrical Engineering from Cornell University, and the MSc degree in Management of Technology from the MIT Sloan School of Management.

    Kate Gunning

    Managing Partner, Focus Academy
    Kate Gunning

    Kate Gunning is focused on strategic market development and technology commercialization for the Life Sciences, Healthcare and Clean technology sectors. Kate’s expertise is evaluating and developing market opportunities in the US for emerging Life science and Healthtech companies and their inventive technologies.
    Kate’s career includes a broad range of Life science and Med tech expertise, from Nuclear Medicine to Clinical Chemistry, Genomics, and Automation, she has worked with both academic and industry leaders.
    With an expansive network both in the US and internationally, she is frequently tapped for advice and guidance on the development of the Biotech and Cleantech industries in the US and overseas. Kate serves as a mentor with Silicon Valley based accelerators, including UC Berkeley’s Center for Entrepreneurship and Technology.

    Pierre-Alexandre Fournier

    Co-founder/CEO, Hexoskin
    Pierre-Alexandre Fournier

    Pierre-Alexandre Fournier is an engineer, scientist, designer and entrepreneur, co-founder and CEO of Hexoskin, a Montreal-based company focused on clinical-grade wearable sensors and AI software for health and clinical research.
    Hexoskin launched in 2013 the first iPhone compatible smart clothing for health monitoring, which won several international awards. In 2018 Hexoskin launched a remote health monitoring system for astronauts doing research aboard the International Space Station. Hexoskin products designed by Pierre-Alexandre and his team are now used by hundreds of research organisations around the world to collect medical data and push the boundaries of medical knowledge in real-life settings. Pierre-Alexandre is also an advocate for transparency in healthcare, patient empowerment, and healthcare innovation through design.

    Richard Bolander

    Senior Wearable Design Engineer, TracPatch Health
    Richard Bolander

    Richard Bolander, PhD, earned his degree in Biomedical Engineering in 2012 with a concentration in impact biomechanics. He currently serves as the head of product development at TracPatch Health, focusing on new product design, algorithm development, intellectual property, clinical studies and other applied research activities. Prior to joining Tracpatch, Dr. Bolander was a concussion researcher and product developer, primarily focusing on algorithms, data science and testing and verification of novel technologies. His most notable work was the development of the Riddell InSite and InSite analytics platforms, which are used to measure head impacts of football players.

    Samir Shah

    Director, AstraZeneca
    Samir Shah

    At AstraZeneca, Dr. Shah develops regulatory strategies to achieve worldwide approval of drug/device combination products, medical devices, and software across all therapeutic areas. He previously worked at Teva Pharmaceuticals where he led regulatory activities leading to approvals of the first integrated smart/digital inhalers, PROAIR DIGIHALER, AIRDUO DIGIHALER, and ARMONAIR DIGIHALER. Previously, he was a formulation scientist at Merck / Schering-Plough for respiratory and nasal products. Dr. Shah earned his B.S. from Case Western Reserve University in Polymer Science Engineering and a PhD in Biomedical Engineering Wake Forest University School of Medicine.

    Sherrie Trigg

    Director of Medical Content and Editor-in-Chief, Medical Design Briefs
    Sherrie Trigg

    Tero-Pekka Alastalo

    Chief Medical Officer and General Manager, US Operations, CardioSignal Inc
    Tero-Pekka Alastalo

    Tero-Pekka Alastalo, MD, PhD is the Chief Medical Officer and GM of US operations at CardioSignal (by Precordior). He is a healthcare entrepreneur, investor, advisor, and board member. He has 10+ years of clinical and translational research experience and is an Adjunct Professor of Pediatrics at the University of Helsinki. He specialized in Pediatric Cardiology and did his postdoctoral training at Stanford University. He was a co-founder of Blueprint Genetics, a genetic testing laboratory for human rare diseases, that was acquired by Quest Diagnostics in 2020. At Blueprint Genetics he had several executive roles from commercial to medical affairs. He left Blueprint Genetics to join CardioSignal in 2021. He is an expert in cardiovascular medicine, genomic medicine, and medical devices for cardiovascular diseases.

    Xina Quan

    Co-founder and CEO, PyrAmes, Inc
    Xina Quan

    Xina Quan is Co-founder and CEO of PyrAmes. Prior to founding PyrAmes in 2016, Xina led R&D efforts at Artificial Muscle Inc. (the first commercial use of electroactive polymers), Cambrios (pioneering the use of silver nanowires in transparent conductive inks), Lumileds Lighting (novel high-power white LED products for mobiles), and DigiLens (switchable holographic gratings).
    Before moving into start-ups, Xina was a Director at AT&T/Lucent Bell Laboratories. She has SB and SM degrees from MIT and a PhD from Princeton, all in Chemical Engineering, and has more than 30 issued or pending US patents.
     

    Exhibitors

    Official Media Partner

    Key Media Partners

    Supporters

    VENUE

    Sheraton Boston Hotel

    39 Dalton Street, Boston, MA, USA

    Travelers will reap benefits of Sheraton Boston Hotel's prime location in downtown Boston, in the thriving neighborhood of Back Bay. Nestled in the heart of the city, our hotel is directly connected to the Prudential Center and steps away from the many shops and restaurants of Copley Place. We're also within walking distance of Fenway Park, the Charles River, Copley Square and much more.

    Aside from a superior Boston, MA location, we also boast an unbeatable array of amenities for your convenience. Break a sweat in our hotel's state-of-the-art fitness center, enjoy the use of New England's largest indoor-outdoor saltwater pool or indulge in some pampering at Green Tangerine Spa & Salon, our full-service salon and spa. We also boast comprehensive meeting and event facilities, perfect for hosting both corporate functions and weddings in downtown Boston. However you choose to spend your time here, we can assure you that the best of the city will be within reach at Sheraton Boston Hotel.
     

    A number of our clients have been approached by third party organisations offering to book hotel rooms. We would advise that you do not book through them as they are not representing the SAE Media Group. SAE Media Group books all hotel rooms directly. If you are approached by a third party organisation then please contact us before making any bookings. If you have already booked a hotel room using a third party organisation, we would highly recommend contacting the hotel you were booked into to ensure a booking has been made for you. We would also advise you to please check the terms and conditions of the booking carefully.
    HOTEL BOOKING FORM

    Biosensors for Medical Wearables Brochure 2022

    Download

    Conference Chair Letter

    Download

    Speaker Biographies

    Download

    Past Attendees

    Download

    Past Presentation - Rhoda Au, Boston University

    Download

    Past Presentation - James Mault, BioIntelliSense

    Download

    Past Presentation - Philip Wilson, Celanese

    Download

    Exhibitors


    Raumedic

    Exhibitors
    http://www.raumedic.com

    Together with its customers, the medical technology company is breaking new ground to improve the diagnosis and treatment of diseases. In doing so, Raumedic focuses on polymer-based solutions for medical and pharmaceutical applications, as well as on products for intensive care. Raumedic has a global presence and a headcount of approximately 1,000. In its core markets of Europe and North America, the company manufactures using its own clean room production facilities.

    Media Partners


    DiMe (Digital Medicine Society)

    Official Media Partner
    https://www.dimesociety.org/

    DiMe is a global non-profit and the professional home for all members of the digital medicine community. Together, we tackle the toughest digital medicine challenges, develop clinical-quality resources on a technology timeline, and deliver these actionable resources to the field via open-source channels and educational programs. Join us to advance the ethical, effective, equitable, and safe use of digital medicine to redefine healthcare and improve lives.

    Media Partners


    American Pharmaceutical Review

    Key Media Partners
    http://www.americanpharmaceuticalreview.com

    Start receiving your free copy today. American Pharmaceutical Review is a review of the drug pipeline from the late discovery phase through manufacturing. American Pharmaceutical Review prides itself on having the most relevant, unbiased and informative editorial in the industry. You will find that all of our editorial is highly technical and written by government agencies, consultants, academics, and large pharmaceuticals companies. American Pharmaceutical Review covers several key topics that are important to drug production:Separations and purification, Drug Delivery, Biopharmaceutical Processing, Biopharmaceutical Development, Formulation development, Manufacturing, Microbiology, Instrumentation, Spectroscopy


    On Drug Delivery

    Key Media Partners
    http://www.ondrugdelivery.com/subscribe

    ONdrugDelivery provides 30,000 readers throughout global pharma/biopharma, with the latest, most pertinent industry information and intelligence about the drug delivery-related ideas, technologies, services and products the sector is developing. Established in 2004, and trusted throughout the industry for its high quality contributions from leading drug delivery experts, ONdrugDelivery is a must for pharma / biotech industry professionals who need to know what’s going on in drug delivery. Subscribe online today to the print or free digital edition: www.ondrugdelivery.com/subscribe.


    Pharma Journalist

    Key Media Partners
    http://www.pharmajournalist.com

    Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry. Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry. Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.


    Medical Design Briefs

    Key Media Partners
    http://WWW.TECHBRIEFS.COM/SUBSCRIBE/MDB/SMIEAST21

    Medical Design Briefs (MDB) is the only publication for the medical OEM market dedicated to medical product design engineers and managers. We offer timely, accurate, quality content and editorial, and we report on engineering-related topics that are at the core of the latest medical technologies. From materials to manufacturing, we dive into the technical side of bringing medical devices to market. From biosensors to cybersecurity, we keep our fingers on the pulse of the hottest trends and topics that may augment or disrupt medical technology.

    Media Partners


    Pharmalicensing

    Supporters
    http://www.pharmalicensing.com

    Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide. Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique online Showcase Profiling & Discover services, as well as its renowned Partnering Search service leveraging its global network of industry experts, to enable companies to identify and engage with appropriate partners around the world. Pharmalicensing is actively utilized by many tens of thousands of industry professionals each month. Pharmalicensing is a division of Cognis Group, Inc.


    MedTech Innovation

    Supporters
    http://www.med-technews.com

    Med-Tech Innovation is the leading multi-platform communication brand for the UK and Irish medical design and manufacturing industries. Our portfolio includes Med-Tech Innovation Expo an annual exhibition and conference; Med-Tech Innovation News a print magazine and online news source; weekly newsletters and an ever-growing social media community. Med-Tech Innovation reaches a unique medical and healthcare audience eager to source solutions to their latest challenges. We connect innovators – whether they be major OEMs or fledgling start-ups –with a community of designers and engineers ready to help bring medical devices to market, quickly and at scale.


    ASD MEDIA

    Supporters
    http://www.asd-network.com

    Professionals in the Aerospace & Defence market use the ASD Media internet platforms to:
    • Be informed on the latest market developments; www.asd-network.com
    • Find the latest business news; www.asd-network.com
    • Find the upcoming events; www.asd-network.com
    • Find companies and organizations; www.asdsource.com
    • Distribute news globally. www.asdwire.com
    The ASD Media platforms are well known and used intensively, your company is able to benefit from these large numbers of users. Be informed with ASD-Network; Create exposure for your company with ASDSource, distribute your news with ASDWire or advertise with us, build your brand and increase traffic to your company’s website.

    For more detailed information please contact with: ASD MEDIA
    Stefan.koopman@asdmedia.nl


    Mass Device

    Supporters
    https://www.massdevice.com/

    MassDevice provides day-to-day coverage of the medtech and medical device industry, with stories about devices that save lives, the people behind them and the trends driving businesses forward. Our reach extends across the industry, with up-to-date news on clinical trials, regulatory processes research and development, financial updates and legal news for spaces including orthopedic devices, surgical robotics, replacement heart valves and plenty more. We’re the most trusted resource in the medical device industry that’s inside the boardroom of every medical device company in the country. Our fully interactive brand focuses on covering the ways in which medtech businesses are offering safer, more effective and cost-efficient treatments around the world. The publication serves the medtech and medical device industry, supplier and contract manufacturers, government organizations/agencies, research hospitals, medical centers, universities and more. Our readers include high-level medtech executives, trade associations, entrepreneurs, corporate and academic researchers, engineers and government officials including regulators. MassDevice is your top resource for all medical device and medtech news, owned by Cleveland-based WTWH Media. We stand by journalistic ethics to provide the most up-to-date, accurate and fairly reported information for our readers.


    Mednous

    Supporters
    http://www.MedNous.com

    MedNous is a print publication and website about medical innovation in Europe. It carries exclusive interviews with companies that are at the forefront of medical technology, as well as contributor articles from prominent practitioners. Our mission is to identify significant advances in medicine and to explain how this innovation is being commercialised. In doing so, we talk to venture capitalists about what products and platforms they are supporting. We report on how regulators cope with the accelerating pace of innovation. And we regularly cover the latest developments in the discovery and development of new medical concepts in the area of antibodies, vaccines, small molecules, regenerative medicine and nanomedicines. MedNous combines the English word for medicine with the Greek word for intellect. And those with nous are readers of our publication. Visit our website: www.mednous.com


    Pharmiweb

    Supporters
    http://www.pharmiweb.com

    Established in October 2003, PharmiWeb Solutions is an energetic, innovative provider of web-based solutions for the pharmaceutical sector, with customers such as AstraZeneca, Roche, Servier Laboratories, and Merck With solutions in three key areas: Online Publishing, e-Business and Mobile Computing, we deliver connectivity – between people and applications – unlocking islands of data and knowledge. We own some of the sector’s most innovative Online Publications: PharmiWeb.com, HospitalPharma.com and Detail-Direct.com. We are actively developing solutions for Mobile Computing platforms. For example, our PharmiTabTM e-pharmacy solution runs real-time patient data and prescribing transactions in a busy hospital environment, on a TabletPC, wireless client/server platform. e-Business solutions range from e-Detailing, to Online Market Research, all designed to increase reach, increase sales, and to reduce administration and costs.


    Pharmacircle

    Supporters
    http://www.pharmacircle.com

    PharmaCircle is an innovative knowledge management company serving the current and future global leaders in the Pharmaceutical and Biotechnology related industries. PharmaCircle is a one stop information and analysis source for pipeline, products, clinical trials, drug delivery technologies, deals and acquisitions, company financials, venture capital investments, product sales, pharmaceutical services, news, patents and more….


    Pharmaceutical Outsourcing

    Supporters
    http://www.pharmoutsourcing.com

    Pharmaceutical Outsourcing, the journal dedicated to pharmaceutical and biopharmaceutical contract services. With regular sections on contract manufacturing, contract research, contract packaging, formulation/development services, contract analytical testing, APIs, stability testing, clinical research and other areas, we bring the most complete coverage of trends and issues in the industry to our 15,000 readers in North America.


    Drug Discovery Today

    Supporters
    http://www.drugdiscoverytoday.com/

    Drug Discovery Today covers the whole of the preclinical drug discovery process. The reviews are cutting edge, written by experts in their respective fields and cover all aspects of drug discovery from genomic and proteomic approaches, computational drug design, medicinal chemistry and the translation of these sciences to therapies.


    Technology Networks

    Supporters
    http://go.technologynetworks.com/subscribe-to-newsletters

    Founded in 2000, Technology Networks is established as the leading news provider for life science and drug discovery professionals. In addition, we provide unique content including webcasts, videos, application notes and posters from recent conferences. Our portfolio now includes around 30 focussed scientific communities, all of which are accessible free of charge within TechnologyNetworks.com

    SAVE TO


    Outlook Calendar  OUTLOOK CALENDAR
    Google Calendar  GOOGLE CALENDAR
    ICal Calendar  ICAL CALENDAR
    Yahoo! Calendar  YAHOO! CALENDAR

    Sheraton Boston Hotel

    39 Dalton Street
    Boston 02199
    USA

    Sheraton Boston Hotel

    Travelers will reap benefits of Sheraton Boston Hotel's prime location in downtown Boston, in the thriving neighborhood of Back Bay. Nestled in the heart of the city, our hotel is directly connected to the Prudential Center and steps away from the many shops and restaurants of Copley Place. We're also within walking distance of Fenway Park, the Charles River, Copley Square and much more.

    Aside from a superior Boston, MA location, we also boast an unbeatable array of amenities for your convenience. Break a sweat in our hotel's state-of-the-art fitness center, enjoy the use of New England's largest indoor-outdoor saltwater pool or indulge in some pampering at Green Tangerine Spa & Salon, our full-service salon and spa. We also boast comprehensive meeting and event facilities, perfect for hosting both corporate functions and weddings in downtown Boston. However you choose to spend your time here, we can assure you that the best of the city will be within reach at Sheraton Boston Hotel.
     

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SAE Media Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@saemediagroup.com

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SAE Media Group

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SAE Media Group , Ground Floor, India House, 45 Curlew Street, London, SE1 2ND, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smgconferences.com Email: events@saemediagroup.com
    Registered in England - SMi Group Ltd trading as SAE Media Group




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.

    Thank you for visiting our event

    If you would like to receive further information about our events, please fill out the information below.

    By ticking above you are consenting to receive information by email from SAE Media Group.
    Full details of our privacy policy can be found here https://www.smgconferences.com/privacy-legals/privacy-policy/.
    Should you wish to update your contact preferences at any time you can contact us at data@smgconferences.com.
    Should you wish to be removed from any future mailing lists please click on the following link http://www.smgconferences.com/opt-out